Topics

Glioblastoma | Treatment | Targeted therapy | Trametinib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Trametinib

Haile H, Upadhyayula PS, Karlovich E, Sisti MB, Gill BJA, Donovan LE.
Management of asynchronous multifocal adult glioblastoma with loss of BRAF^V600E -mutant clonality: a case report.
Acta Neuropathol Commun. 2025 Jan 28;13(1):18. doi: 10.1186/s40478-024-01894-w. PMID: 39871343. Case report. ˍ

Salama AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF^V600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H.
JCO Precis Oncol. 2026 Jan 14;10:e2500338. doi: 10.1200/PO-25-00338. PMID: 41533998. Interventional study. ˍ